Image_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_8_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_2_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_4_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_2_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_6_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table 1_Ferula (Ferula elaeochytris) as a phytoestrogen: Use of Ferula in laying hens.docx by Arda Onur Özkök (20595461)

“…FRP-1 and FRP-2 groups, however, were fed a diet supplemented with 1 g/kg and 2 g/kg FRP, respectively. …”

Table_5_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_4_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.PNG by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

Image_5_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.TIFF by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

Image_3_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.TIFF by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

Reversion of pH-Induced Physiological Drug Resistance: A Novel Function of Copolymeric Nanoparticles by Rutian Li (203852)

“…Weakly basic anticancer drugs will be protonated extracellularly and display a decreased intracellular concentration. In this study, we show that copolymeric nanoparticles (NPs) are able to overcome this “pH-induced physiological drug resistance” (PIPDR) by delivering drugs to the cancer cells via endocytosis rather than passive diffussion.…”

Image_2_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.TIFF by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

Image_1_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.TIFF by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

Table_1_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.pdf by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

A serine/threonine phosphatase and kinase oppositely regulate hemolytic activity of <i>S. aureus</i>. by Kellie Burnside (247478)

“…<p>(<b>A</b>) A transposon (Tn5EZ) insertion in <i>stp1</i> (53E12) decreased hemolytic activity whereas the strain with the Tn5EZ insertion in <i>stk1</i> (60C1) increased hemolytic activity compared to the isogenic WT Newman. …”

Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study by Ronac Mamtani (2626705)

“…We confirmed a decreased risk of colorectal cancer with statin use (long-term: odds ratio [OR], 0.95; 95% confidence interval [CI], 0.91–0.99; short-term: OR, 0.92; 95% CI, 0.85–0.99). …”

Comparative levels of differentially expressed genes over time in a murine staphylococcal SSTI model. by Rebecca A. Brady (408084)

“…Transcripts that are common to multiple time points are shown by the overlap. (A) Significantly increased transcripts in infected ears compared to non-infected ears from the same challenged mice (local response); (B) Significantly decreased transcripts in infected ears compared to non-infected ears from the same challenged mice (local response); (C) Significantly increased transcripts in the non-infected ears of challenged mice compared to naïve mice (systemic response); (D) Significantly decreased transcripts in the non-infected ears of challenged mice compared to naïve mice (systemic response).…”